GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Clinical trials for GERD (GASTROESOPHAGEAL REFLUX DISEASE) explained in plain language.
Never miss a new study
Get alerted when new GERD (GASTROESOPHAGEAL REFLUX DISEASE) trials appear
Sign up with your email to follow new studies for GERD (GASTROESOPHAGEAL REFLUX DISEASE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New heartburn drug aims to outperform standard treatment in major trial
Disease control Not yet recruitingThis study is testing whether a new medication called linaprazan glurate works better than the commonly used drug lansoprazole at keeping the esophagus healed in people with acid reflux disease (GERD). About 1050 adults who have already had their esophagus damage healed in a prev…
Matched conditions: GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Phase: PHASE3 • Sponsor: Cinclus Pharma Holding AB • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Surgeons test new method to prevent heartburn after achalasia surgery
Disease control Not yet recruitingThis study compares two versions of a minimally invasive throat surgery for achalasia, a rare swallowing disorder. Researchers want to see if preserving certain muscle fibers during the procedure reduces acid reflux afterward while still effectively treating the swallowing proble…
Matched conditions: GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Phase: NA • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New pill aims to outperform standard heartburn drug in healing damaged esophagus
Disease control Not yet recruitingThis study is testing if a new drug called linaprazan glurate works better than the common medication lansoprazole at healing damage in the esophagus caused by severe acid reflux (GERD). About 500 adults with confirmed esophageal damage will be randomly assigned to take one of tw…
Matched conditions: GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Phase: PHASE3 • Sponsor: Cinclus Pharma Holding AB • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC